Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene

Steroids

Volumn 70, Issue 13, 2005, Pages 847-855

  Bashir, A ^a   Mak, Y T ^a   Sankaralingam, S ^a   Cheung, J ^a   Mc Gowan, N W A ^b   Grigoriadis, A E ^b   Fogelman, I ^c   Hampson, G ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

Estrogen; Mononuclear cells; OPG; RANK; RANKL

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; KLIOVANCE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RALOXIFENE; RECEPTOR ACTIVATOR OF NK KAPPA B; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BONE DENSITY; BONE MINERAL; BONE REMODELING; BONE TURNOVER; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION REGULATION; HIP; HUMAN; HUMAN CELL; IN VITRO STUDY; LUMBAR SPINE; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTMENOPAUSE OSTEOPOROSIS; RNA ANALYSIS; SPINE;

AGED; BONE DENSITY; BONE RESORPTION; CARRIER PROTEINS; COLLAGEN; COLLAGEN TYPE I; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HORMONE REPLACEMENT THERAPY; HUMANS; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OSTEOPOROSIS; OSTEOPROTEGERIN; PEPTIDES; POSTMENOPAUSE; RALOXIFENE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 27644477040     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2005.04.011     Document Type: Article

References (33)

1. B.L. Riggs, S. Khosla, and L.J. Melton Sex steroids and the construction and conservation of the adult skeleton Endocr Rev 23 2001 279 302
2. R. Pacifici Estrogen, cytokines and pathogenesis of post-menopausal osteoporosis J Bone Miner Res 11 1996 1043 1051
3. S.C. Manolagas, and R.L. Jilka Bone marrow, cytokines and bone remodeling N Engl J Med 332 1995 305 311
4. L.C. Hofbauer, S. Khosla, C.R. Dunstan, D.L. Lacey, W.J. Boyle, and B.L. Riggs The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption J Bone Miner Res 15 2000 2 12
5. L.C. Hofbauer, S. Khosla, C.R. Dunstan, D.L. Lacey, T.C. Spelsberg, and B.L. Riggs Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells Endocrinology 140 1999 4367 4370
6. S. Khosla, E.J. Arkinson, C.R. Dunstan, and W.M. O'Fallon Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men J Clin Endocrinol Metab 87 2002 1550 1554
7. G. Eghbali-Fatoureli, S. Khosla, A. Sanyal, W.J. Boyle, D.L. Lacey, and B.L. Riggs Role of RANK ligand in mediating increased bone resorption in early postmenopausal women J Clin Invest 111 2003 1221 1230
8. L.C. Hofbauer, M. Schoppet, P. Schuller, V. Viereck, and M. Christ Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women Clin Endocrinol 60 2004 214 219
9. M.A. Anderson, E. Maraskovsky, W.L. Billingsey, W.C. Dougall, M.E. Tometsko, and E.R. Roux A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function Nature 390 1997 175 179
10. K.B. Tan, J. Harrop, M. Reddy, P. Young, J. Terrett, and J. Emery Characterisation of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily of genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells Gene 204 1997 35 46
11. C. Roggia, Y. Gao, S. Cenci, M.N. Weitzman, G. Toraldo, and G. Isaia Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo Proc Natl Acad Sci USA 98 2001 13960 13965
12. O. Bernard-Poenaru, C. Roux, R. Blanque, C. Gardner, De Vernejoul Mc, and M.E. Cohen-Solal Bone-resorbing cytokines from peripheral blood mononuclear cells after replacement therapy: a longitudinal study Osteoporos Int 12 2001 769 776
13. M.E. Cohen-Solal, A.M. Graulet, M.A. Denne, J. Gueris, D. Baylink, and M.C. De Vernejoul Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines J Clin Endocrinol Metab 77 1993 1648 1653
14. V. Shalhoub, G. Elliott, L. Chiu, R. Manoukian, M. Kelley, and N. Hawkins Characterisation of osteoclast precursors in human blood Br J Haematol 111 2000 501 512
15. K. Yano, E. Tsuda, N. Washida, F. Kobayashi, M. Goto, and A. Harada Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in post-menopausal women with osteoporosis J Bone Miner Res 14 1999 518 527
16. L.G. Heaney, J. McKirgan, C.F. Stanford, and M. Ennis Electronic cell counting to measure total cell numbers in bronchoalveolar lavage fluid Eur Respir J 7 1994 1527 1531
17. J.N.S. Matthews, D.G. Altman, M.J. Campbell, and P. Royston Analysis of serial measurements in medical research Br Med J 300 1990 230 235
18. S. Cenci, M.N. Weitzman, C. Roggia, N. Namba, D. Novack, and J. Woodring J Clin Invest 106 2000 1229 1237
19. S. Cenci, G. Toraldo, M.N. Weitzman, C. Roggia, Y. Gao, and W.P. Qian Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator Proc Natl Acad Sci USA 100 2003 10405 10410
20. R. Pacifici, C. Brown, E. Puscheck, E. Friedrich, E. Slatopolsky, and D. Maggio Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells Proc Natl Acad Sci USA 88 1991 5134 5138
21. D.J. Torgerson, and S.E.M. Bell-Sayer HRT and prevention of nonvertebral fractures JAMA 285 2001 2891 2897
22. B. Ettinger, D.M. Black, B.H. Mitlak, R.K. Knickerbocker, T. Nickelsen, and H.K. Genant Reduction in vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3 year randomised clinical trial JAMA 282 1999 637 745
23. C.H. Chestnut, N.H. Bell, G.S. Clark, B.L. Drinkwater, S.C. English, and C.C. Johnsson Hormone replacement therapy in post-menopausal women: urinary N-telopeptide of type 1 collagen monitors therapeutic effect and predicts response of bone mineral density Am J Med 102 1997 29 37
24. M. Saika, D. Inoue, S. Kido, and T. Matsumoto 17-β estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2 via estrogen receptor-α Endocrinol 142 2001 2205 2212
25. J. Cheung, Y.T. Mak, S. Papaioannou, B.A.J. Evans, I. Fogelman, and G. Hampson Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-β oestradiol and raloxifene J Endocrinol 177 2003 423 433
26. T. Masuzawa, C. Miyaura, Y. Onoe, K. Kusano, H. Ohta, and S. Nozawa Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow J Clin Invest 94 1994 1090 1097
27. N.K. Shevde, and J.W. Pike Estrogen modulates the recruitment of myelopoietic cell progenitors in rat through a stromal cell-independent mechanism involving apoptosis Blood 87 1996 2683 2692
28. R.G. Erben, S. Raith, J. Eberle, and M. Stangassinger Ovariectomy augments B lymphopoiesis and generation of monocyte-macrophage precursors in rat bone marrow Am J Physiol 274 1998 476 483
29. N.K. Shevde, A.C. Bendixen, K.M. Dienger, and J.W. Pike Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression Proc Natl Acad Sci USA 97 2000 7829 7834
30. S. Khosla, L.J. Melton, and B.L. Riggs Estrogen and the male skeleton J Clin Endocrinol Metab 87 2002 1443 1450
31. M. Jevon, A. Sabokbar, Y. Fujikawa, T. Hirayama, S.D. Neale, and J. Wass Gender- and age-related differences in osteoclast formation from circulating precursors J Endocrinol 172 3 2002 673 681
32. A. Taranta, M. Brama, A. Tete, V. De Luca, R. Scandurra, and G. Spera The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro Bone 30 2002 368 376
33. S. Srivasta, G. Toraldo, M.N. Weitzmann, S. Cenci, F.P. Ross, and R. Pacifici Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-κb ligand (RANKL)-induced JNK activation J Biol Chem 276 2001 8836 8840